Inactive Instrument

Applied Genetic Technologies Corporation Stock price

Equities

AGTC

US03820J1007

Biotechnology & Medical Research

Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 67 22-11-30
Chief Tech/Sci/R&D Officer - 22-06-07
Chief Tech/Sci/R&D Officer 47 22-11-30
Members of the board TitleAgeSince
Chief Executive Officer 67 22-11-30
Director/Board Member 50 22-11-30
Director/Board Member - 22-11-30
More insiders
Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company uses gene therapy platform to develop genetic therapies for patients suffering from rare and debilitating diseases. Its focus is on the field of ophthalmology where it has active clinical programs in X-linked retinitis pigmentosa (XLRP), achromatopsia (ACHM) and a optogenetics program, as well as a preclinical program in dry age-related macular degeneration (dAMD). It has approximately one preclinical program in otology and two preclinical programs targeting central nervous system disorders (CN), including frontotemporal dementia and amyotrophic lateral sclerosis. Its optogenetics program is being developed in collaboration with Bionic Sight, LLC and its otology program is being developed in collaboration with Otonomy, Inc. In addition to its product pipeline, the Company has also developed broad technological and manufacturing capabilities in synthetic promoter development and optimization.
More about the company
  1. Stock
  2. Equities
  3. Stock Applied Genetic Technologies Corporation - Nasdaq